이식형 인슐린 펌프 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2034년)

Implantable Insulin Pumps Market (Device Type: Closed-loop Insulin Pump and Open-loop Insulin Pump; and Disease Indication: Type I Diabetes and Type II Diabetes) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

US $ 5,795 ￦ 8,606,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,795 ￦ 13,062,000

PDF (Multi-user License)

PDF 보고서를 동일 부서 5명이 이용할 수 있는 라이선스입니다. 텍스트 등의 Copy & Paste가 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 11,795 ￦ 17,517,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

이 보고서는 2024-2034년까지의 예측 기간 동안 시장 지표에 대한 귀중한 인사이트를 얻기 위해 과거뿐만 아니라 현재의 성장 동향과 기회를 조사하여 세계 이식형 인슐린 펌프 시장을 조사합니다. 이 보고서는 2024년을 기준 연도로, 2034년을 예측 연도로 간주하여 2018-2034년 세계 이식형 인슐린 펌프 시장의 수익과 예측을 제공합니다. 또한 2024년부터 2034년까지 세계 이식형 인슐린 펌프 시장의 연평균 성장률(CAGR %)을 제시합니다.

이 보고서는 광범위한 조사를 통해 작성되었습니다. 1차 조사에서 애널리스트는 주요 오피니언 리더, 업계 리더, 오피니언 메이커를 대상으로 인터뷰를 진행했습니다. 2차 조사에서는 주요 기업의 제품 자료, 연례 보고서, 보도자료, 관련 자료 등을 참고하여 이식형 인슐린 펌프 시장을 추론했습니다.

시장 스냅샷
2023년 시장 규모	31억 달러
2034년 시장 규모	78억 달러
CAGR	8.3%

이 보고서는 세계 이식형 인슐린 펌프 시장의 경쟁 환경을 조사하고 있습니다. 세계 이식형 인슐린 펌프 시장에서 활동하는 주요 기업들이 확인되었으며, 각 기업들은 다양한 속성으로 프로파일링되었습니다. 회사 개요, 재무 상태, 최근 동향, SWOT 등은 이 보고서에서 다루는 세계 이식형 인슐린 펌프 시장 기업의 속성입니다.

목차

제1장 서문

제2장 가정과 조사 방법

제3장 주요 요약 : 시장

제4장 시장 개요

• 소개
• 개요
• 시장 역학
• 시장 분석과 예측, 2020-2034년

제5장 주요 인사이트

• 파이프라인 분석
• 주요 제품·브랜드 분석
• 주요 인수합병
• COVID-19에 의한 산업에 대한 영향

제6장 세계의 시장 분석과 예측 : 디바이스 유형별

• 소개와 정의
• 주요 조사 결과·발전
• 시장 금액 예측 : 디바이스 유형별, 2020-2034년
  • 폐 루프 인슐린 펌프
  • 오픈 루프 인슐린 펌프
• 시장 매력 분석 : 디바이스 유형별

제7장 세계의 시장 분석과 예측 : 적응 질환별

• 소개와 정의
• 주요 조사 결과·발전
• 시장 금액 예측 : 적응 질환별, 2020-2034년
  • 1형 당뇨병
  • 2형 당뇨병
• 시장 매력 분석 : 적응 질환별

제8장 세계의 시장 분석과 예측 : 최종사용자별

• 소개와 정의
• 주요 조사 결과·발전
• 시장 금액 예측 : 최종사용자별, 2020-2034년
  • 병원
  • 클리닉
  • 홈케어 설정
  • 기타
• 시장 매력 분석 : 최종사용자별

제9장 세계의 시장 분석과 예측 : 지역별

• 주요 조사 결과
• 시장 금액 예측 : 지역별, 2020-2034년
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동 및 아프리카
• 시장 매력 분석 : 지역별

제10장 북미의 시장 분석과 예측

제11장 유럽의 시장 분석과 예측

제12장 아시아태평양의 시장 분석과 예측

제13장 라틴아메리카의 시장 분석과 예측

제14장 중동 및 아프리카의 시장 분석과 예측

제15장 경쟁 상황

• 시장 기업 - 경쟁 매트릭스(기업 계층과 규모별)
• 시장 점유율 분석 : 기업별(2023년)
• 기업 개요
  • Medtronic plc
  • F. Hoffmann-La Roche AG
  • SOOIL Developments Co. Ltd.
  • Diamesco Co., Ltd.
  • Apex Medical Devices
  • Tandem Diabetes Care
  • Johnson & Johnson
  • Insulet Corporation
  • Aetna Inc.
  • Diabeloop SACA

ksm

영문 목차

영문목차

Implantable Insulin Pumps Market - Scope of Report

TMR's report on the global implantable insulin pumps market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global implantable insulin pumps market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global implantable insulin pumps market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the implantable insulin pumps market.

Market Snapshot
Market Value in 2023	US$ 3.1 Bn
Market Value in 2034	US$ 7.8 Bn
CAGR	8.3%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global implantable insulin pumps market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global implantable insulin pumps market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global implantable insulin pumps market.

The report delves into the competitive landscape of the global implantable insulin pumps market. Key players operating in the global implantable insulin pumps market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global implantable insulin pumps market profiled in this report.

Key Questions Answered in Global implantable insulin pumps Market Report:

• What is the sales/revenue generated by implantable insulin pumps across all regions during the forecast period?
• What are the opportunities in the global implantable insulin pumps market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2034?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Implantable Insulin Pumps Market - Research Objectives and Research Approach

The comprehensive report on the global implantable insulin pumps market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global implantable insulin pumps market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global implantable insulin pumps market.

Table of Contents

1. Preface

• 1.1. Market Definition and Scope
• 1.2. Market Segmentation
• 1.3. Key Research Objectives
• 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Implantable Insulin Pumps Market

4. Market Overview

• 4.1. Introduction
  • 4.1.1. Product Definition
  • 4.1.2. Industry Evolution/Developments
• 4.2. Overview
• 4.3. Market Dynamics
  • 4.3.1. Drivers
  • 4.3.2. Restraints
  • 4.3.3. Opportunities
• 4.4. Implantable Insulin Pumps Market Analysis and Forecast, 2020-2034

5. Key Insights

• 5.1. Pipeline Analysis
• 5.2. Key Product /Brand Analysis
• 5.3. Key Mergers & Acquisitions
• 5.4. COVID-19 Pandemic Impact on Industry

6. Global Implantable Insulin Pumps Market Analysis and Forecast, by Device Type

• 6.1. Introduction & Definition
• 6.2. Key Findings/Developments
• 6.3. Market Value Forecast, by Device Type, 2020-2034
  • 6.3.1. Closed-loop Insulin Pump
  • 6.3.2. Open-loop Insulin Pump
• 6.4. Market Attractiveness Analysis, by Device Type

7. Global Implantable Insulin Pumps Market Analysis and Forecast, by Disease Indication

• 7.1. Introduction & Definition
• 7.2. Key Findings/Developments
• 7.3. Market Value Forecast, by Disease Indication, 2020-2034
  • 7.3.1. Type I Diabetes
  • 7.3.2. Type II Diabetes
• 7.4. Market Attractiveness Analysis, by Disease Indication

8. Global Implantable Insulin Pumps Market Analysis and Forecast, by End-user

• 8.1. Introduction & Definition
• 8.2. Key Findings/Developments
• 8.3. Market Value Forecast, by End-user, 2020-2034
  • 8.3.1. Hospitals
  • 8.3.2. Clinics
  • 8.3.3. Homecare Settings
  • 8.3.4. Others (Research Institutes, etc.)
• 8.4. Market Attractiveness Analysis, by End-user

9. Global Implantable Insulin Pumps Market Analysis and Forecast, by Region

• 9.1. Key Findings
• 9.2. Market Value Forecast, by Region, 2020-2034
  • 9.2.1. North America
  • 9.2.2. Europe
  • 9.2.3. Asia Pacific
  • 9.2.4. Latin America
  • 9.2.5. Middle East & Africa
• 9.3. Market Attractiveness Analysis, by Region

10. North America Implantable Insulin Pumps Market Analysis and Forecast

• 10.1. Introduction
• 10.2. Key Findings
• 10.3. Market Value Forecast, by Device Type, 2020-2034
  • 10.3.1. Closed-loop Insulin Pump
  • 10.3.2. Open-loop Insulin Pump
• 10.4. Market Value Forecast, by Disease Indication, 2020-2034
  • 10.4.1. Type I Diabetes
  • 10.4.2. Type II Diabetes
• 10.5. Market Value Forecast, by End-user, 2020-2034
  • 10.5.1. Hospitals
  • 10.5.2. Clinics
  • 10.5.3. Homecare Settings
  • 10.5.4. Others (Research Institutes, etc.)
• 10.6. Market Value Forecast, by Country, 2020-2034
  • 10.6.1. U.S.
  • 10.6.2. Canada
• 10.7. Market Attractiveness Analysis
  • 10.7.1. By Device Type
  • 10.7.2. By Disease Indication
  • 10.7.3. By End-user
  • 10.7.4. By Country

11. Europe Implantable Insulin Pumps Market Analysis and Forecast

• 11.1. Introduction
• 11.2. Key Findings
• 11.3. Market Value Forecast, by Device Type, 2020-2034
  • 11.3.1. Closed-loop Insulin Pump
  • 11.3.2. Open-loop Insulin Pump
• 11.4. Market Value Forecast, by Disease Indication, 2020-2034
  • 11.4.1. Type I Diabetes
  • 11.4.2. Type II Diabetes
• 11.5. Market Value Forecast, by End-user, 2020-2034
  • 11.5.1. Hospitals
  • 11.5.2. Clinics
  • 11.5.3. Homecare Settings
  • 11.5.4. Others (Research Institutes, etc.)
• 11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
  • 11.6.1. Germany
  • 11.6.2. U.K.
  • 11.6.3. France
  • 11.6.4. Italy
  • 11.6.5. Spain
  • 11.6.6. Rest of Europe
• 11.7. Market Attractiveness Analysis
  • 11.7.1. By Device Type
  • 11.7.2. By Disease Indication
  • 11.7.3. By End-user
  • 11.7.4. By Country/Sub-region

12. Asia Pacific Implantable Insulin Pumps Market Analysis and Forecast

• 12.1. Introduction
• 12.2. Key Findings
• 12.3. Market Value Forecast, by Device Type, 2020-2034
  • 12.3.1. Closed-loop Insulin Pump
  • 12.3.2. Open-loop Insulin Pump
• 12.4. Market Value Forecast, by Disease Indication, 2020-2034
  • 12.4.1. Type I Diabetes
  • 12.4.2. Type II Diabetes
• 12.5. Market Value Forecast, by End-user, 2020-2034
  • 12.5.1. Hospitals
  • 12.5.2. Clinics
  • 12.5.3. Homecare Settings
  • 12.5.4. Others (Research Institutes, etc.)
• 12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
  • 12.6.1. China
  • 12.6.2. Japan
  • 12.6.3. India
  • 12.6.4. Australia & New Zealand
  • 12.6.5. Rest of Asia Pacific
• 12.7. Market Attractiveness Analysis
  • 12.7.1. By Device Type
  • 12.7.2. By Disease Indication
  • 12.7.3. By End-user
  • 12.7.4. By Country/Sub-region

13. Latin America Implantable Insulin Pumps Market Analysis and Forecast

• 13.1. Introduction
• 13.2. Key Findings
• 13.3. Market Value Forecast, by Device Type, 2020-2034
  • 13.3.1. Closed-loop Insulin Pump
  • 13.3.2. Open-loop Insulin Pump
• 13.4. Market Value Forecast, by Disease Indication, 2020-2034
  • 13.4.1. Type I Diabetes
  • 13.4.2. Type II Diabetes
• 13.5. Market Value Forecast, by End-user, 2020-2034
  • 13.5.1. Hospitals
  • 13.5.2. Clinics
  • 13.5.3. Homecare Settings
  • 13.5.4. Others (Research Institutes, etc.)
• 13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
  • 13.6.1. Brazil
  • 13.6.2. Mexico
  • 13.6.3. Rest of Latin America
• 13.7. Market Attractiveness Analysis
  • 13.7.1. By Device Type
  • 13.7.2. By Disease Indication
  • 13.7.3. By End-user
  • 13.7.4. By Country/Sub-region

14. Middle East & Africa Implantable Insulin Pumps Market Analysis and Forecast

• 14.1. Introduction
• 14.2. Key Findings
• 14.3. Market Value Forecast, by Device Type, 2020-2034
  • 14.3.1. Closed-loop Insulin Pump
  • 14.3.2. Open-loop Insulin Pump
• 14.4. Market Value Forecast, by Disease Indication, 2020-2034
  • 14.4.1. Type I Diabetes
  • 14.4.2. Type II Diabetes
• 14.5. Market Value Forecast, by End-user, 2020-2034
  • 14.5.1. Hospitals
  • 14.5.2. Clinics
  • 14.5.3. Homecare Settings
  • 14.5.4. Others (Research Institutes, etc.)
• 14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
  • 14.6.1. GCC Countries
  • 14.6.2. South Africa
  • 14.6.3. Rest of Middle East & Africa
• 14.7. Market Attractiveness Analysis
  • 14.7.1. By Device Type
  • 14.7.2. By Disease Indication
  • 14.7.3. By End-user
  • 14.7.4. By Country/Sub-region

15. Competition Landscape

• 15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
• 15.2. Market Share Analysis, by Company (2023)
• 15.3. Company Profiles
  • 15.3.1. Medtronic plc
    • 15.3.1.1. Company Overview
    • 15.3.1.2. Product Portfolio
    • 15.3.1.3. SWOT Analysis
    • 15.3.1.4. Financial Overview
    • 15.3.1.5. Strategic Overview
  • 15.3.2. F. Hoffmann-La Roche AG
    • 15.3.2.1. Company Overview
    • 15.3.2.2. Product Portfolio
    • 15.3.2.3. SWOT Analysis
    • 15.3.2.4. Financial Overview
    • 15.3.2.5. Strategic Overview
  • 15.3.3. SOOIL Developments Co. Ltd.
    • 15.3.3.1. Company Overview
    • 15.3.3.2. Product Portfolio
    • 15.3.3.3. SWOT Analysis
    • 15.3.3.4. Financial Overview
    • 15.3.3.5. Strategic Overview
  • 15.3.4. Diamesco Co., Ltd.
    • 15.3.4.1. Company Overview
    • 15.3.4.2. Product Portfolio
    • 15.3.4.3. SWOT Analysis
    • 15.3.4.4. Financial Overview
    • 15.3.4.5. Strategic Overview
  • 15.3.5. Apex Medical Devices
    • 15.3.5.1. Company Overview
    • 15.3.5.2. Product Portfolio
    • 15.3.5.3. SWOT Analysis
    • 15.3.5.4. Financial Overview
    • 15.3.5.5. Strategic Overview
  • 15.3.6. Tandem Diabetes Care
    • 15.3.6.1. Company Overview
    • 15.3.6.2. Product Portfolio
    • 15.3.6.3. SWOT Analysis
    • 15.3.6.4. Financial Overview
    • 15.3.6.5. Strategic Overview
  • 15.3.7. Johnson & Johnson
    • 15.3.7.1. Company Overview
    • 15.3.7.2. Product Portfolio
    • 15.3.7.3. SWOT Analysis
    • 15.3.7.4. Financial Overview
    • 15.3.7.5. Strategic Overview
  • 15.3.8. Insulet Corporation
    • 15.3.8.1. Company Overview
    • 15.3.8.2. Product Portfolio
    • 15.3.8.3. SWOT Analysis
    • 15.3.8.4. Financial Overview
    • 15.3.8.5. Strategic Overview
  • 15.3.9. Aetna Inc.
    • 15.3.9.1. Company Overview
    • 15.3.9.2. Product Portfolio
    • 15.3.9.3. SWOT Analysis
    • 15.3.9.4. Financial Overview
    • 15.3.9.5. Strategic Overview
  • 15.3.10. Diabeloop SACA
    • 15.3.10.1. Company Overview
    • 15.3.10.2. Product Portfolio
    • 15.3.10.3. SWOT Analysis
    • 15.3.10.4. Financial Overview
    • 15.3.10.5. Strategic Overview